Delivery Order SPE2DB20D3505-SPE2DB23FU5K2
- Not listed
- This federal contract award is for the delivery of Clindamycin PH 1% Gel, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,024.82 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,329.36, is for the delivery of Clindamycin PH 1% gel, a topical antibiotic medication, with a completion date of December 18, 2023. This contract is a Delivery Order, with a Firm Fixed Price pricing type. The award is not associated with a set-aside designation, indicating open competition....
- This federal contract award, valued at $1,141.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Clindamycin PH 1% gel, a pharmaceutical product, with a completion date of February 12, 2024. The contract is a firm-fixed-price type and does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award, valued at $2,983.01, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Clindamycin PH 1% Gel 30GM, a pharmaceutical product, to support the DLA Troop Support Medical program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of Clindamycin Phosphate 1% Gel, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 7, 2022, with a ceiling value of $1,091.86. The contract is a Firm Fixed Price Delivery Order, with a completion date of March 8, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566751973 - CLINDAMYCIN PH 1% GEL 30GM. The contract is a Delivery Order with a Firm Fixed Price of $1,187.18 and an ultimate completion date of December 19, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp, a for-profit corporate entity, has an extensive track record of federal contract awards with...
- This federal contract award, valued at $3,200.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565577245 - Clindamycin PH 1% Gel, 30GM, with an ultimate completion date of August 27, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of Clindamycin Phosphate 1% Gel, in 30-gram tubes, to the Defense Logistics Agency (DLA). The $1,821.87 Firm Fixed Price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 4, 2024. The contract has an ultimate completion date of January 5, 2024 and was not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,065.08 firm fixed-price delivery order is for the supply of Clindamycin PH 1% Gel 30GM, a pharmaceutical product. The contract has an ultimate completion date of March 31, 2025. There is no set-aside designation, indicating this was an open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award, valued at $1,280.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563343710 - Clindamycin PH 1% Gel 30GM, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of January 18, 2024. The award is associated with a larger Indefinite Delivery...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FU5K2Delivery Order
This federal contract award is for the delivery of Clindamycin PH 1% Gel, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a firm fixed price of $2,710.82. The award has an ultimate completion date of August 9, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award appears to be a delivery order under that larger IDC. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/8/23 |